BSE: LUPIN - Lupin Limited

Yield per half year: +2.91%
Dividend yield: 0.2475%

Share chart Lupin Limited

Extended chart Simple chart
Financial Markets by TradingView

About Lupin Limited

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs).

more details
The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

ISIN INE326A01037
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.2475
Дивиденд ао 8
Сайт https://www.lupin.com
Цена ао 2063
Change price per day: +0.4363% (2063)
Change price per week: +0.0507% (2070.95)
Change price per month: +5.23% (1969.05)
Change price per 3 month: +2.33% (2024.9)
Change price per half year: +2.91% (2013.5)
Change price per year: +26.63% (1636.25)
Change price per 3 year: +202.64% (684.65)
Change price per 5 year: +195.98% (700.05)
Change price per year to date: -3.52% (2147.55)
All parameters

Underestimation

Title Value Grade
P/S 3.73 5
P/BV 5.1 3
P/E 38.27 4
EV/EBITDA 17.69 6
Total: 6.25

Efficiency

Title Value Grade
ROA, % 8.15 3
ROE, % 14.31 4
Total: 2.33

Dividends

Title Value Grade
Div yield, % 0.2475 0.63
DSI 0.9286 9.29
Total: 4.05

Debt

Title Value Grade
Debt/EBITDA 2.37 6
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 27.85 4
Yield Ebitda, % -34.8 0
Yield EPS, % -799.78 0
Total: 2.8
More

Head Job title Payment Year of birth
Ms. Vinita D. Gupta CEO & Executive Director 109.2M 1968 (57 years)
Mr. Nilesh Deshbandhu Gupta MD & Executive Director 49.6M 1974 (51 year)
Mr. Ramesh Swaminathan Global CFO, CRO, Head of Corporate Affairs & Executive Director 66.86M 1966 (59 years)
Mr. Christoph Funke Chief Technical Operations Officer
Mr. Sreeji Gopinathan Chief Information Officer
Dr. Shahin Fesharaki Global Chief Scientific Officer
Mr. Ravi Agrawal Sr. Vice President of Investor Relations and M&A
Dr. Sofia Mumtaz President of Legal and Compliance of Australia, Japan & Canada Business
Mr. Amit Kumar Gupta Company Secretary & Compliance Officer
Ms. Rajalakshmi Azariah Vice President & Global Head of Corporate Communications

Address: India, Mumbai, Kalpataru Inspire - open in Google maps, open in Yandex maps
Website: https://www.lupin.com